<?xml version='1.0' encoding='utf-8'?>
<document id="29065786"><sentence text="Severe liver toxicity in a chronic myeloid leukemia patient probably induced by a drug interaction between imatinib and sertraline."><entity charOffset="107-115" id="DDI-PubMed.29065786.s1.e0" text="imatinib" /><entity charOffset="120-130" id="DDI-PubMed.29065786.s1.e1" text="sertraline" /><pair ddi="false" e1="DDI-PubMed.29065786.s1.e0" e2="DDI-PubMed.29065786.s1.e0" /><pair ddi="false" e1="DDI-PubMed.29065786.s1.e0" e2="DDI-PubMed.29065786.s1.e1" /></sentence><sentence text="Our objective is to describe a chronic myeloid leukemia patient with a severe liver toxicity likely due to a drug-drug interaction between imatinib and sertraline"><entity charOffset="139-147" id="DDI-PubMed.29065786.s2.e0" text="imatinib" /><entity charOffset="152-162" id="DDI-PubMed.29065786.s2.e1" text="sertraline" /><pair ddi="false" e1="DDI-PubMed.29065786.s2.e0" e2="DDI-PubMed.29065786.s2.e0" /><pair ddi="false" e1="DDI-PubMed.29065786.s2.e0" e2="DDI-PubMed.29065786.s2.e1" /></sentence><sentence text=" The patient started treatment with sertraline three months after starting imatinib"><entity charOffset="75-83" id="DDI-PubMed.29065786.s3.e0" text="imatinib" /></sentence><sentence text=" From the beginning of sertraline treatment, the patient developed vomiting, and five weeks later she developed a severe hepatic failure and was admitted to the hospital"><entity charOffset="23-33" id="DDI-PubMed.29065786.s4.e0" text="sertraline" /></sentence><sentence text=" The Naranjo nomogram showed a probable correlation between this adverse effect and the interaction between imatinib and sertraline"><entity charOffset="108-116" id="DDI-PubMed.29065786.s5.e0" text="imatinib" /><entity charOffset="121-131" id="DDI-PubMed.29065786.s5.e1" text="sertraline" /><pair ddi="false" e1="DDI-PubMed.29065786.s5.e0" e2="DDI-PubMed.29065786.s5.e0" /><pair ddi="false" e1="DDI-PubMed.29065786.s5.e0" e2="DDI-PubMed.29065786.s5.e1" /></sentence><sentence text=" This interaction is extremely rare and the mechanism of action is not clear; it could be a mix of pharmacokinetic and pharmacodynamic processes" /><sentence text=" To our knowledge, this is the first case in medical literature of a severe liver toxicity due to an interaction between imatinib and sertraline"><entity charOffset="121-129" id="DDI-PubMed.29065786.s7.e0" text="imatinib" /><entity charOffset="134-144" id="DDI-PubMed.29065786.s7.e1" text="sertraline" /><pair ddi="false" e1="DDI-PubMed.29065786.s7.e0" e2="DDI-PubMed.29065786.s7.e0" /><pair ddi="false" e1="DDI-PubMed.29065786.s7.e0" e2="DDI-PubMed.29065786.s7.e1" /></sentence><sentence text=" This interaction is also not described in the main secondary data sources, such as Lexicomp® and Micromedex®" /><sentence text=" However, due to the severity of this event, the hepatic function should be carefully monitored in patients treated with imatinib and sertraline"><entity charOffset="121-129" id="DDI-PubMed.29065786.s9.e0" text="imatinib" /><entity charOffset="134-144" id="DDI-PubMed.29065786.s9.e1" text="sertraline" /><pair ddi="false" e1="DDI-PubMed.29065786.s9.e0" e2="DDI-PubMed.29065786.s9.e0" /><pair ddi="false" e1="DDI-PubMed.29065786.s9.e0" e2="DDI-PubMed.29065786.s9.e1" /></sentence><sentence text="" /></document>